Yuan L, Fang B, Wang M, Wang T, Huang S, Yang T, Zhao S
Department of Medical Genetics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005 P. R. China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998 Oct 10;15(5):297-9.
The main feature of phenylketonuria(PKU) is mental retardation. Although classical PKU is defined as that the hepatic phenylalanine hydroxylase (PAH) activity ranges 0-1% of normal enzyme, the untreated PKU patients show a wide range of intellectual phenotype. This study sought to find the molecular basis of such variation of intellectual phenotype among PKU.
45 classical PKU patients included in the research were screened for detecting six mutant alleles which were rather common among Chinese PKU patients, i.e. R243Q, R413P, Y204C, Y356X, W326X and R111X. PCR-ASO and PCR-SSCP techniques were used. The expression of those mutant PAH genes was analysed by methods of site-directed mutagencies. 27 PKU patients whose two mutant alleles were both defined were involved in this study. The IQ of these patients were tested by DDST system.
Among 27 patients, 4/27 (15%) were mild retardation, 10/27(37%) were moderate, the severe mental retardation accounted for 12/27(44%). The relationship between genotype and intellectual phenotype in this group was examined. It was found that the intellectual phenotype of 8 patients were compatible with genotype but not well matched in 19 cases. The enzyme activity of Y204C expressed in vitro was 100%, but all 3 patients with Y204C/Y204C were severely mental retarded. Enzyme activities of R413P and Y356X were <3% and 0 respectively in expression analysis, but the patients in this group had mild or moderate mental retardation.
Intellectual phenotype was not well matched with the genotype in classical PKU patients, so that genotype can not be used to predicte the intellectual phenotype in PKU patients.
苯丙酮尿症(PKU)的主要特征是智力发育迟缓。虽然经典型PKU被定义为肝脏苯丙氨酸羟化酶(PAH)活性为正常酶活性的0 - 1%,但未经治疗的PKU患者表现出广泛的智力表型。本研究旨在探寻PKU患者智力表型这种变异的分子基础。
对纳入研究的45例经典型PKU患者进行筛查,以检测在中国PKU患者中较为常见的六个突变等位基因,即R243Q、R413P、Y204C、Y356X、W326X和R111X。采用聚合酶链反应-等位基因特异性寡核苷酸探针杂交(PCR-ASO)和聚合酶链反应-单链构象多态性分析(PCR-SSCP)技术。通过定点突变方法分析这些突变PAH基因的表达。本研究纳入了27例两个突变等位基因均已明确的PKU患者。这些患者的智商通过丹佛发育筛查测验(DDST)系统进行测试。
在27例患者中,4/27(15%)为轻度智力发育迟缓,10/27(37%)为中度,重度智力发育迟缓占12/27(44%)。研究了该组患者基因型与智力表型之间的关系。发现8例患者的智力表型与基因型相符,但19例并不完全匹配。体外表达的Y204C酶活性为100%,但所有3例Y204C/Y204C患者均为重度智力发育迟缓。在表达分析中,R413P和Y356X的酶活性分别<3%和0,但该组患者为轻度或中度智力发育迟缓。
经典型PKU患者的智力表型与基因型不完全匹配,因此基因型不能用于预测PKU患者的智力表型。